Literature DB >> 14756623

The tumor cell and telomerase.

M L Altshuler1, S E Severin, A I Glukhov.   

Abstract

Imbalanced activity of the mechanism that controls cell division is a prerequisite for malignant transformation of a normal cell. The present review considers this multi-step mechanism, which is usually called the G1-S checkpoint. Besides, tumor cells are characterized by the presence of telomerase, an enzyme responsible for restoration of chromosome ends after replication and thus providing for unlimited cell division. The main point of the present article is to find out whether the activation of telomerase is controlled by the G1-S checkpoint or does not depend on it. The principal components of the G1-S checkpoint, such as cyclin-dependent kinases, retinoblastoma and E2F proteins, control the activity of telomerase. In their turn, they accumulate and transmit signals from various sources inside and outside the cell. Thus, various changes in tumor cells can activate telomerase through the G1-S checkpoint. Such are the suggested effects on telomerase of Myc, p53, Waf1, protein kinases B and C, Wnt5A, TGFbeta, WT1, and estrogens. However, Myc, p53, WT1, estrogens, protein kinases B and C, and TGFbeta can also directly influence telomerase independently of the G1-S checkpoint mechanism. Moreover, in 30% of human tumors the gene of the key subunit of telomerase (hTERT) is amplified, possibly due to chromosomal rearrangements unassociated with the activity of the G1-S checkpoint. Thus, telomerase seems to be activated not by a single agent but due to combined action of various factors, both with involvement of the G1-S checkpoint mechanism and independently of it.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14756623     DOI: 10.1023/b:biry.0000011648.51641.04

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  4 in total

1.  Emerging role of transcription factor-microRNA-target gene feed-forward loops in cancer.

Authors:  Qian Wu; Hua Qin; Qiu Zhao; Xing-Xing He
Journal:  Biomed Rep       Date:  2015-06-11

2.  Anti-tumor effect of 5-aza-2'-deoxycytidine by inhibiting telomerase activity in hepatocellular carcinoma cells.

Authors:  Shuang-Fen Tao; Chang-Song Zhang; Xian-Ling Guo; Yun Xu; Shan-Shan Zhang; Jian-Rui Song; Rong Li; Meng-Chao Wu; Li-Xin Wei
Journal:  World J Gastroenterol       Date:  2012-05-21       Impact factor: 5.742

3.  Methylation of CDKN2B CpG islands is associated with upregulated telomerase activity in children with acute lymphoblastic leukemia.

Authors:  Qian Hu; Xiaowen Chen; Sixi Liu; Ruiqi Wen; Xiuli Yuan; Dandan Xu; Guosheng Liu; Feiqiu Wen
Journal:  Oncol Lett       Date:  2017-02-09       Impact factor: 2.967

4.  Suramin increased telomerase activity in the c6 glioma/wistar experimental brain tumor model.

Authors:  Mine Ergüven; Ayhan Bilir; Tuncay Altug; Fadime Aktar; Nuriye Akev
Journal:  Int J Biomed Sci       Date:  2007-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.